Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(11):943-949; doi:10.1093/jnci/91.11.943
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Peto, J.
Right arrow Articles by Stratton, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peto, J.
Right arrow Articles by Stratton, M. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 11, 943-949, June 2, 1999
© 1999 Oxford University Press

Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer

Julian Peto, Nadine Collins, Rita Barfoot, Sheila Seal, William Warren, Nazneen Rahman, Douglas F. Easton, Christopher Evans, Judith Deacon, Michael R. Stratton

Affiliations of authors: J. Peto, Section of Epidemiology, Institute of Cancer Research, Surrey, U.K., and London School of Hygiene and Tropical Medicine, London, U.K.; N. Collins, R. Barfoot, S. Seal, W. Warren, N. Rahman, M. R. Stratton, Section of Cancer Genetics, Institute of Cancer Research; D. F. Easton, CRC Genetic Epidemiology Group, Strangeways Laboratories, Cambridge, U.K.; C. Evans, J. Deacon, Section of Epidemiology, Institute of Cancer Research.

Correspondence to: Michael R. Stratton, M.B.B.S., Ph.D., Haddow Laboratories, Institute of Cancer Research, 15 Cotswold Rd., Sutton, Surrey, SM2 5NG, U.K. (e-mail: mikes{at}icr.ac.uk).

BACKGROUND: Mutations in the BRCA1 and BRCA2 genes are found in most families with cases of both breast and ovarian cancer or with many cases of early-onset breast cancer. However, in an outbred population, the prevalence of BRCA1 and BRCA2 mutations in patients with breast cancer who were unselected for a family history of this disease has not been determined. METHODS: Mutations in the BRCA1 and BRCA2 genes were detected in blood samples from two population-based series of young patients with breast cancer from Britain. RESULTS: Mutations were detected in 15 (5.9%) of 254 women diagnosed with breast cancer before age 36 years (nine [3.5%] in BRCA1 and six [2.4%] in BRCA2) and in 15 (4.1%) of 363 women diagnosed from ages 36 through 45 years (seven [1.9%] in BRCA1 and eight [2.2%] in BRCA2). Eleven percent (six of 55) of patients with a first-degree relative who developed ovarian cancer or breast cancer by age 60 years were mutation carriers, compared with 45% (five of 11) of patients with two or more affected first- or second-degree relatives. The standardized incidence ratio for breast cancer in mothers and sisters was 365 (five observed and 1.37 expected) for 30 mutation carriers and 199 (64 observed and 32.13 expected) for 587 noncarriers. If we assume recent penetrance estimates, the respective proportions of BRCA1 and BRCA2 mutation carriers are 3.1% and 3.0%, respectively, of patients with breast cancer who are younger than age 50 years, 0.49% and 0.84% of patients with breast cancer who are age 50 years or older, and 0.11% and 0.12% of women in the general population. CONCLUSIONS: Mutations in the BRCA1 and BRCA2 genes make approximately equal contributions to early-onset breast cancer in Britain and account for a small proportion of the familial risk of breast cancer.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
D S P Tan, C Marchio, and J S Reis-Filho
Hereditary breast cancer: from molecular pathology to tailored therapies
J. Clin. Pathol., October 1, 2008; 61(10): 1073 - 1082.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. T. Lynch, J. N. Marcus, and W. S. Rubinstein
Stemming the Tide of Cancer for BRCA1/2 Mutation Carriers
J. Clin. Oncol., September 10, 2008; 26(26): 4239 - 4243.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose, et al.
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics
J. Med. Genet., July 1, 2008; 45(7): 425 - 431.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Schaapveld, O. Visser, M. J. Louwman, E. G.E. de Vries, P. H.B. Willemse, R. Otter, W. T.A. van der Graaf, J.-W. W. Coebergh, and F. E. van Leeuwen
Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study
J. Clin. Oncol., March 10, 2008; 26(8): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. Schrading and C. K. Kuhl
Mammographic, US, and MR Imaging Phenotypes of Familial Breast Cancer
Radiology, January 1, 2008; 246(1): 58 - 70.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. M. John, A. Miron, G. Gong, A. I. Phipps, A. Felberg, F. P. Li, D. W. West, and A. S. Whittemore
Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups
JAMA, December 26, 2007; 298(24): 2869 - 2876.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. J. Vogel, D. P. Atchley, J. Erlichman, K. R. Broglio, K. J. Ready, V. Valero, C. I. Amos, G. N. Hortobagyi, K. H. Lu, and B. Arun
BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model
J. Clin. Oncol., October 10, 2007; 25(29): 4635 - 4641.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. D. Treszezamsky, L. A. Kachnic, Z. Feng, J. Zhang, C. Tokadjian, and S. N. Powell
BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase II
Cancer Res., August 1, 2007; 67(15): 7078 - 7081.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P Sasieni
Phenocopies in families seen by cancer geneticists
J. Med. Genet., June 1, 2007; 44(6): e82 - e82.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Johnson, O. Fletcher, C. Palles, M. Rudd, E. Webb, G. Sellick, I. dos Santos Silva, V. McCormack, L. Gibson, A. Fraser, et al.
Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility
Hum. Mol. Genet., May 1, 2007; 16(9): 1051 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Rahman and R. H. Scott
Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players
Hum. Mol. Genet., April 15, 2007; 16(R1): R60 - R66.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
H. I.J. Wildschut, T.J. Peters, and C. P. Weiner
Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis
Hum. Reprod. Update, September 1, 2006; 12(5): 499 - 512.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. E. Malone, J. R. Daling, D. R. Doody, L. Hsu, L. Bernstein, R. J. Coates, P. A. Marchbanks, M. S. Simon, J. A. McDonald, S. A. Norman, et al.
Prevalence and Predictors of BRCA1 and BRCA2 Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years
Cancer Res., August 15, 2006; 66(16): 8297 - 8308.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. Walsh, S. Casadei, K. H. Coats, E. Swisher, S. M. Stray, J. Higgins, K. C. Roach, J. Mandell, M. K. Lee, S. Ciernikova, et al.
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
JAMA, March 22, 2006; 295(12): 1379 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. A. Oldenburg, K. Kroeze-Jansema, H. Meijers-Heijboer, C. J. van Asperen, N. Hoogerbrugge, I. van Leeuwen, H. F.A. Vasen, A.-M. Cleton-Jansen, J. Kraan, J. J. Houwing-Duistermaat, et al.
Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping.
Clin. Cancer Res., March 15, 2006; 12(6): 1693 - 1700.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. G. Natarajan, N. Ganesan, P. Carter-Nolan, C. A. Tucker, P. G. Shields, and L. L. Adams-Campbell
{gamma}-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 437 - 442.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Colilla, P. W. Kantoff, S. L. Neuhausen, A. K. Godwin, M. B. Daly, S. A. Narod, J. E. Garber, H. T. Lynch, M. Brown, B. L. Weber, et al.
The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers
Carcinogenesis, March 1, 2006; 27(3): 599 - 605.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Chenevix-Trench, S. Healey, S. Lakhani, P. Waring, M. Cummings, R. Brinkworth, A. M. Deffenbaugh, L. A. Burbidge, D. Pruss, T. Judkins, et al.
Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variants of Unknown Clinical Significance
Cancer Res., February 15, 2006; 66(4): 2019 - 2027.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P K Lovelock, S Healey, W Au, E Y M Sum, A Tesoriero, E M Wong, S Hinson, R Brinkworth, A Bekessy, O Diez, et al.
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants
J. Med. Genet., January 1, 2006; 43(1): 74 - 83.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. A. Hill, E. Gilbert, G. M. Dores, M. Gospodarowicz, F. E. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund, C. F. Lynch, et al.
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
Blood, November 15, 2005; 106(10): 3358 - 3365.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
M Kristiansen, G P S Knudsen, P Maguire, S Margolin, J Pedersen, A Lindblom, and K H Orstavik
High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer
J. Med. Genet., November 1, 2005; 42(11): 877 - 880.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
U.S. Preventive Services Task Force*
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement
Ann Intern Med, September 6, 2005; 143(5): 355 - 361.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. D. Nelson, L. H. Huffman, R. Fu, and E. L. Harris
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force
Ann Intern Med, September 6, 2005; 143(5): 362 - 379.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. R. Lakhani, J. S. Reis-Filho, L. Fulford, F. Penault-Llorca, M. van der Vijver, S. Parry, T. Bishop, J. Benitez, C. Rivas, Y.-J. Bignon, et al.
Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype
Clin. Cancer Res., July 15, 2005; 11(14): 5175 - 5180.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C J Fabian, B F Kimler, M S Mayo, and S A Khan
Breast-tissue sampling for risk assessment and prevention
Endocr. Relat. Cancer, June 1, 2005; 12(2): 185 - 213.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. N. Freedman, D. Seminara, M. H. Gail, P. Hartge, G. A. Colditz, R. Ballard-Barbash, and R. M. Pfeiffer
Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
J Natl Cancer Inst, May 18, 2005; 97(10): 715 - 723.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
B Leegte, A H van der Hout, A M Deffenbaugh, M K Bakker, I M Mulder, A ten Berge, E P Leenders, J Wesseling, J de Hullu, N Hoogerbrugge, et al.
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations
J. Med. Genet., March 1, 2005; 42(3): e20 - e20.
[Full Text] [PDF]


Home page
JAMAHome page
E. B. Claus, S. Petruzella, E. Matloff, and D. Carter
Prevalence of BRCA1 and BRCA2 Mutations in Women Diagnosed With Ductal Carcinoma In Situ
JAMA, February 23, 2005; 293(8): 964 - 969.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
B.A.J. PONDER, A. ANTONIOU, A. DUNNING, D.F. EASTON, and P.D.P. PHAROAH
Polygenic Inherited Predisposition to Breast Cancer
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 35 - 41.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Hartikainen, H. Tuhkanen, V. Kataja, A. M. Dunning, A. Antoniou, P. Smith, A. Arffman, M. Pirskanen, D. F. Easton, M. Eskelinen, et al.
An Autosome-Wide Scan for Linkage Disequilibrium-Based Association in Sporadic Breast Cancer Cases in Eastern Finland: Three Candidate Regions Found
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 75 - 80.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S-W Kim, C S Lee, J V Fey, P I Borgen, and J Boyd
Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases
J. Med. Genet., January 1, 2005; 42(1): e5 - e5.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. Chunder, S. Mandal, A. Roy, S. Roychoudhury, and C. K. Panda
Differential Association of BRCA1 and BRCA2 Genes with Some Breast Cancer-Associated Genes in Early and Late Onset Breast Tumors
Ann. Surg. Oncol., December 1, 2004; 11(12): 1045 - 1055.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Wagner, K. Hemminki, E. Grzybowska, R. Klaes, D. Butkiewicz, J. Pamula, W. Pekala, H. Zientek, D. Mielzynska, E. Siwinska, et al.
The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer
Carcinogenesis, December 1, 2004; 25(12): 2473 - 2478.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. Sifri, S. Gangadharappa, and L. S. Acheson
Identifying and Testing for Hereditary Susceptibility to Common Cancers
CA Cancer J Clin, November 1, 2004; 54(6): 309 - 326.
[Abstract] [Full Text] [PDF]


Home page
Journal of Health ManagementHome page
M. S. Selvan, A. V. Wilkinson, R. Chamberlain, and M. L. Bondy
Social and Dietary Changes Associated with Obesity and Breast Cancer Risk
Journal of Health Management, October 1, 2004; 6(2): 103 - 114.
[Abstract] [PDF]


Home page
J. Med. Genet.Home page
D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, and F Lalloo
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO
J. Med. Genet., June 1, 2004; 41(6): 474 - 480.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. H. Choi, M. H. Lee, A. E. Bale, D. Carter, and B. G. Haffty
Incidence of BRCA1 and BRCA2 Mutations in Young Korean Breast Cancer Patients
J. Clin. Oncol., May 1, 2004; 22(9): 1638 - 1645.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. M. Suter, R. M. Ray, Y. W. Hu, M. G. Lin, P. Porter, D. L. Gao, R. E. Zaucha, L. M. Iwasaki, L. P. Sabacan, M. C. Langlois, et al.
BRCA1 and BRCA2 Mutations in Women from Shanghai China
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 181 - 189.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H Hampel, K Sweet, J A Westman, K Offit, and C Eng
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
J. Med. Genet., February 1, 2004; 41(2): 81 - 91.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. J. van Asperen, M. A. Jonker, C. E. Jacobi, J. E. M. van Diemen-Homan, E. Bakker, M. H. Breuning, J. C. van Houwelingen, and G. H. de Bock
Risk Estimation for Healthy Women from Breast Cancer Families: New Insights and New Strategies
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 87 - 93.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. A. Jonker, C. E. Jacobi, W. E. Hoogendoorn, N. J. D. Nagelkerke, G. H. de Bock, and J. C. van Houwelingen
Modeling Familial Clustered Breast Cancer Using Published Data
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1479 - 1485.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Oldenburg, K. Kroeze-Jansema, J. Kraan, H. Morreau, J. G. M. Klijn, N. Hoogerbrugge, M. J. L. Ligtenberg, C. J. van Asperen, H. F. A. Vasen, C. Meijers, et al.
The CHEK2*1100delC Variant Acts as a Breast Cancer Risk Modifier in Non-BRCA1/BRCA2 Multiple-Case Families
Cancer Res., December 1, 2003; 63(23): 8153 - 8157.
[Abstract] [Full Text] [PDF]


Home page
Journal of Health Politics, Policy and LawHome page
J. Stevens
Racial Meanings and Scientific Methods: Changing Policies for NIH-Sponsored Publications Reporting Human Variation
Journal of Health Politics Policy and Law, December 1, 2003; 28(6): 1033 - 1088.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Moullan, D. G. Cox, S. Angele, P. Romestaing, J.-P. Gerard, and J. Hall
Polymorphisms in the DNA Repair Gene XRCC1, Breast Cancer Risk, and Response to Radiotherapy
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1168 - 1174.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
M. M. de Jong, I. M. Nolte, E. G. E. de Vries, M. Schaapveld, J. H. Kleibeuker, E. Oosterom, J. C. Oosterwijk, A. H. van der Hout, G. van der Steege, M. Bruinenberg, et al.
The HLA class III subregion is responsible for an increased breast cancer risk
Hum. Mol. Genet., September 15, 2003; 12(18): 2311 - 2319.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. Kuschel, A. Auranen, C. S. Gregory, N. E. Day, D. F. Easton, B. A. J. Ponder, A. M. Dunning, and P. D. P. Pharoah
Common Polymorphisms in Checkpoint Kinase 2 Are not Associated with Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 809 - 812.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
K. Hemminki, H. Zhang, and K. Czene
Time Trends and Familial Risks in Squamous Cell Carcinoma of the Skin
Arch Dermatol, July 1, 2003; 139(7): 885 - 889.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C E Jacobi, M A Jonker, N J D Nagelkerke, J C van Houwelingen, and G H de Bock
Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care
J. Med. Genet., July 1, 2003; 40(7): e83 - 83.
[Full Text] [PDF]


Home page
JCOHome page
H. Meijers-Heijboer, C. T.M. Brekelmans, M. Menke-Pluymers, C. Seynaeve, A. Baalbergen, C. Burger, E. Crepin, A. W.M. van den Ouweland, B. van Geel, and J. G.M. Klijn
Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation
J. Clin. Oncol., May 1, 2003; 21(9): 1675 - 1681.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. S. Dite, M. A. Jenkins, M. C. Southey, J. S. Hocking, G. G. Giles, M. R. E. McCredie, D. J. Venter, and J. L. Hopper
Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations
J Natl Cancer Inst, March 19, 2003; 95(6): 448 - 457.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. M. Domchek, A. Eisen, K. Calzone, J. Stopfer, A. Blackwood, and B. L. Weber
Application of Breast Cancer Risk Prediction Models in Clinical Practice
J. Clin. Oncol., February 15, 2003; 21(4): 593 - 601.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Hearle, B. E. Damato, J. Humphreys, J. Wixey, H. Green, J. Stone, D. F. Easton, and R. S. Houlston
Contribution of Germline Mutations in BRCA2, P16INK4A, P14ARF and P15 to Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 458 - 462.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. F. Boyd, G. S. Dite, J. Stone, A. Gunasekara, D. R. English, M. R.E. McCredie, G. G. Giles, D. Tritchler, A. Chiarelli, M. J. Yaffe, et al.
Heritability of Mammographic Density, a Risk Factor for Breast Cancer
N. Engl. J. Med., September 19, 2002; 347(12): 886 - 894.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. B. Begg
On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
J Natl Cancer Inst, August 21, 2002; 94(16): 1221 - 1226.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. J. Swerdlow, B. L. De Stavola, B. Floderus, N. V. Holm, J. Kaprio, P. K. Verkasalo, and T. Mack
Risk Factors for Breast Cancer at Young Ages in Twins: An International Population-Based Study
J Natl Cancer Inst, August 21, 2002; 94(16): 1238 - 1246.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Forsti, Q. Jin, E. Grzybowska, M. Soderberg, H. Zientek, M. Sieminska, J. Rogozinska-Szczepka, E. Chmielik, B. Utracka-Hutka, and K. Hemminki
Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer
Carcinogenesis, August 1, 2002; 23(8): 1315 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
B. Kuschel, A. Auranen, S. McBride, K. L. Novik, A. Antoniou, J. M. Lipscombe, N. E. Day, D. F. Easton, B. A.J. Ponder, P. D.P. Pharoah, et al.
Variants in DNA double-strand break repair genes and breast cancer susceptibility
Hum. Mol. Genet., June 1, 2002; 11(12): 1399 - 1407.
[Abstract] [Full Text] [PDF]


Home page